Dren Bio raises $350 million for late-stage drug development
Dren Bio closed an oversubscribed $350 million private round co-led by Juvia Group and Lightspeed, taking venture funding above $500 million as it advances dibotatug.
Topic
Dibotatug
Topic
Topic
Topic
Dren Bio closed an oversubscribed $350 million private round co-led by Juvia Group and Lightspeed, taking venture funding above $500 million as it advances dibotatug.